| Protocol |
Antagonist |
734 (74.5%) |
131 (74.0%) |
0.887 |
| Long |
251 (25.5%) |
46 (26.0%) |
| Procedure |
ICSI |
941 (95.5%) |
172 (97.2%) |
0.317 |
| IVF |
44 (4.5%) |
5 (2.8%) |
| Total gonadotropin Dose |
Median (IQR) |
1800 (2700 - 1350) |
2025 (3225 - 1225) |
0.196 |
| Number of eggs |
Median (IQR) |
7 (10 - 5) |
7 (10 - 4.5) |
0.693 |
| Number of embryos generated |
Median (IQR) |
4 (6 - 2) |
4 (6 - 2) |
0.787 |
| Number of embryos transferred |
1 |
169 (17.2%) |
35 (19.8%) |
0.400 |
| 2 |
795 (80.7%) |
140 (79.1%) |
0.618 |
| 3 |
21 (2.1%) |
2 (1.1%) |
0.378 |
| ET Day |
2 |
287 (29.1%) |
54 (30.5%) |
0.712 |
| 3 |
582 (59.1%) |
107 (60.5%) |
0.733 |
| 4 |
48 (4.9%) |
9 (5.1%) |
0.904 |
| 5 |
68 (6.9%) |
7 (4.0%) |
0.142 |
| FSH drug |
Recombinant FSH (Gonal-F) |
528 (53.6%) |
86 (48.6%) |
0.218 |
| Human menopausal gonadotropin (Merional) |
397 (40.3%) |
74 (41.8%) |
0.708 |
| Recombinant FSH (Gonal-F) + Human menopausal gonadotropin (Merional) |
48 (4.9%) |
14 (7.9%) |
0.098 |
| Recombinant FSH (Gonal-F) + recombinant LH (Lutropin alfa) |
12 (1.2%) |
3 (1.7%) |
0.605 |